SCHEMBL31661283

SCHEMBL31661283

CCOC(=O)c1nc(N)sc1-c1csc(Nc2ccc(Cl)cn2)n1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.67
KMT2A Q03164 7/20 0.67
SMN1; SMN2 Q16637 6/20 0.67
MAPT P10636 6/20 0.67
USP2 O75604 2/20 0.67
HSD17B10 Q99714 2/20 0.67
LMNA P02545 1/20 0.67
TSHR P16473 1/20 0.67
TRPV4 Q9HBA0 8/20 0.58
NPC1 O15118 5/20 0.52
RAB9A P51151 4/20 0.52
KDM4E B2RXH2 5/20 0.51
STAT3 P40763 1/20 0.51
NFKB1 P19838 2/20 0.48
NFKB2 Q00653 2/20 0.48
RELA Q04206 2/20 0.48
MAPK1 P28482 1/20 0.48
XBP1 P17861 1/20 0.47
AHR P35869 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31661332 0.85 MEN1 (0.64) MEN1KMT2ASMN1; SMN2MAPTUSP2
SCHEMBL31661232 0.84 TRPV4 (0.52) MEN1KMT2ASMN1; SMN2MAPTUSP2
SCHEMBL31661228 0.80 MEN1 (0.65) MEN1KMT2ASMN1; SMN2MAPTUSP2
SCHEMBL525388 0.80 EGFR (0.58) MEN1KMT2ASMN1; SMN2MAPTUSP2
SCHEMBL31661254 0.79 MEN1 (0.72) MEN1KMT2ASMN1; SMN2MAPTUSP2
SCHEMBL31661318 0.78 MEN1 (0.71) MEN1KMT2ASMN1; SMN2MAPTUSP2
SCHEMBL31661286 0.77 MEN1 (0.69) MEN1KMT2ASMN1; SMN2MAPTUSP2
SCHEMBL525917 0.75 RAB9A (0.50) MEN1KMT2ASMN1; SMN2MAPTUSP2
SCHEMBL10670662 0.74 ALDH1A1 (0.57) MEN1KMT2ASMN1; SMN2MAPTHSD17B10
SCHEMBL31661216 0.73 MEN1 (0.77) MEN1KMT2ASMN1; SMN2MAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151517-A1 THIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS ASSOCIATED WITH MISSFOLDING OF ALPHA-SYNUCLEIN PROTEIN WAVEBREAK THERAPEUTICS LIMITED (US) 2025-07-17 WO disclosed